Does TRICHLORMETHIAZIDE Cause Interstitial lung disease? 7 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Interstitial lung disease have been filed in association with TRICHLORMETHIAZIDE. This represents 2.1% of all adverse event reports for TRICHLORMETHIAZIDE.
7
Reports of Interstitial lung disease with TRICHLORMETHIAZIDE
2.1%
of all TRICHLORMETHIAZIDE reports
3
Deaths
5
Hospitalizations
How Dangerous Is Interstitial lung disease From TRICHLORMETHIAZIDE?
Of the 7 reports, 3 (42.9%) resulted in death, 5 (71.4%) required hospitalization, and 4 (57.1%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TRICHLORMETHIAZIDE. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does TRICHLORMETHIAZIDE Cause?
Dyspnoea (105)
Cough (104)
Drug ineffective (103)
Obstructive airways disorder (103)
Pneumonia (101)
Bronchial secretion retention (97)
Eosinophil count increased (97)
Multiple allergies (97)
Pulmonary mass (97)
Sputum culture positive (97)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which TRICHLORMETHIAZIDE Alternatives Have Lower Interstitial lung disease Risk?
TRICHLORMETHIAZIDE vs TRICLOSAN
TRICHLORMETHIAZIDE vs TRIENTINE
TRICHLORMETHIAZIDE vs TRIENTINE TETRAHYDROCHLORIDE
TRICHLORMETHIAZIDE vs TRIFAROTENE
TRICHLORMETHIAZIDE vs TRIFLUOPERAZINE